Marshall Wace, LLP Alkermes Plc. Transaction History

Marshall Wace, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $28.3 Million - $33.3 Million	1,042,937 Added 143.84%	1,768,014 $49.5 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $17.3 Million - $20.6 Million	611,673 Added 539.38%	725,077 $22.7 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $2.49 Million - $2.98 Million	113,404 New	113,404 $2.96 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $451,793 - $675,059	-21,043 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $491,774 - $676,111	21,043 New	21,043 $649,000
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $872,095 - $1.11 Million	-47,891 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $737,042 - $1.06 Million	47,891 New	47,891 $955,000
Q2 2020 Aug 13, 2020	SELL	$13.31 - $19.41 $253,728 - $370,012	-19,063 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $2.76 Million - $4.49 Million	-211,383 Reduced 91.73%	19,063 $275,000
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $2.97 Million - $3.73 Million	171,730 Added 292.48%	230,446 $4.7 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $1.15 Million - $1.43 Million	58,716 New	58,716 $1.15 Million
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $27,546 - $47,894	-1,283 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $35,847 - $57,234	1,283 New	1,283 $38,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.84B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.